Chronic Kidney Disease Stage 3: What the Numbers Mean
Chronic kidney disease stage 3 refers to a moderate reduction in kidney function, characterised by an estimated glomerular filtration rate (eGFR) of between 30 and 59 mL/min/1.73m². Stage 3 is further
Chronic kidney disease stage 3 refers to a moderate reduction in kidney function, characterised by an estimated glomerular filtration rate (eGFR) of between 30 and 59 mL/min/1.73m². Stage 3 is further divided into G3a (eGFR 45–59) and G3b (eGFR 30–44). These categories describe the degree of functional reduction — they do not constitute a diagnosis for any individual.
Understanding what CKD classification means, how eGFR and creatinine relate to those categories, and why a single test result tells only part of the picture is important for anyone trying to make sense of kidney-function numbers. If you need a focused primer first, this eGFR CKD-EPI explainer provides helpful background.
What Does CKD Mean?
CKD stands for chronic kidney disease — a term used to describe a persistent reduction in kidney function or evidence of kidney damage lasting three months or more. "Chronic" in this context means ongoing rather than temporary. It does not necessarily mean severe, rapidly progressing or immediately life-limiting.
The kidneys perform a range of vital functions: filtering waste products from the blood, regulating fluid balance, producing hormones involved in blood pressure control and red blood cell production, and maintaining electrolyte levels. When kidney function is reduced, these processes can be affected over time.
An important principle in CKD classification is persistence. A single reduced eGFR result, or one elevated creatinine, does not on its own establish a CKD classification. Results can fluctuate due to temporary factors such as dehydration, acute illness, certain medications, or recent strenuous exercise. CKD classification is typically considered when kidney-function abnormalities are present consistently over at least three months.
Practical Insight: Looking at kidney-function results over time provides considerably more meaningful information than focusing on a single number in isolation. A pattern of results, interpreted in appropriate clinical context, is far more informative than any one measurement.
How Many Stages of Chronic Kidney Disease Are There?
There are five main eGFR-based categories used in CKD classification, commonly referred to as G1 through to G5. These categories were developed as part of the international KDIGO (Kidney Disease: Improving Global Outcomes) framework and are widely used in UK clinical practice.
Crucially, stage 3 — or G3 — is subdivided into G3a and G3b, making the full categorisation system six categories rather than a simple ladder of five identical rungs. This distinction matters clinically because the two substages carry different implications for monitoring and management.
The categories are:
- G1 — eGFR ≥90
- G2 — eGFR 60–89
- G3a — eGFR 45–59
- G3b — eGFR 30–44
- G4 — eGFR 15–29
- G5 — eGFR <15
It is also important to note that G1 and G2 require other evidence of kidney damage to qualify for CKD classification — a high or mildly reduced eGFR alone, without accompanying evidence of damage, does not meet the criteria.
CKD Stages and eGFR: A Reference Table
The following table summarises the recognised eGFR-based CKD categories and their general interpretation. This is provided for educational reference only.
| CKD Category | eGFR Range (mL/min/1.73m²) | General Interpretation |
|---|---|---|
| G1 | ≥90 | Normal or high eGFR — CKD classification requires other evidence of kidney damage |
| G2 | 60–89 | Mildly decreased — CKD classification requires other evidence of kidney damage |
| G3a | 45–59 | Mild to moderately decreased kidney function |
| G3b | 30–44 | Moderately to severely decreased kidney function |
| G4 | 15–29 | Severely decreased kidney function |
| G5 | <15 | Kidney failure |
This CKD classification table — sometimes referred to as a CKD chart or GFR stages chart — provides a framework for understanding where a particular eGFR result sits within recognised categories. It does not describe an inevitable progression from one stage to the next.
Practical Insight: CKD grading is a descriptive framework, not a prediction. Many people in categories G3a or G3b do not progress to more severe stages, particularly with appropriate clinical monitoring and management of contributing risk factors.
What Does CKD Stage 3 Mean?
Stage 3 chronic kidney disease — designated as G3 in the KDIGO framework — indicates a moderate reduction in kidney function. The eGFR range for the full G3 category spans from 30 to 59 mL/min/1.73m², and it is divided into two substages for important reasons:
- G3a (eGFR 45–59): Mild to moderately decreased. Kidney function is reduced but the kidneys are still filtering a meaningful proportion of what would be expected for a healthy young adult.
- G3b (eGFR 30–44): Moderately to severely decreased. This substage carries a greater degree of functional reduction and may be associated with a higher likelihood of requiring specialist renal review.
The distinction between G3a and G3b matters because the two groups may have different monitoring requirements, different risk profiles for complications, and different clinical management approaches. Grouping all G3 patients together under one label would obscure these clinically meaningful differences.
It is equally important to understand that a single eGFR result in the G3 range does not automatically establish that a person has CKD at that stage. As noted above, CKD classification considers persistence over time alongside other relevant clinical and laboratory information.
Practical Insight: CKD staging provides a shared language for describing kidney function. It is a framework, not a fixed verdict. Clinical interpretation should always involve a healthcare professional with access to the full picture of an individual’s health.
eGFR vs Creatinine: Understanding the Relationship
Two terms appear repeatedly when discussing kidney function: creatinine and eGFR. They are related but not the same.
Creatinine is a waste product produced naturally by the breakdown of creatine phosphate in muscle tissue. It is filtered from the blood by the kidneys and excreted in urine. When kidney function is reduced, creatinine can accumulate in the blood, and a blood test can measure its concentration.
eGFR (estimated glomerular filtration rate) is not directly measured — it is calculated using the creatinine level alongside other individual information such as age, sex, and (depending on the equation used) ethnicity or body size. The resulting number estimates the rate at which the kidneys are filtering blood per minute, per 1.73 square metres of body surface area.
The reason eGFR is preferred over creatinine alone in CKD classification is that creatinine levels vary considerably between individuals based on factors including:
- Muscle mass — individuals with greater muscle mass tend to produce more creatinine
- Age — creatinine production tends to decrease with age as muscle mass declines
- Sex — biological differences in muscle mass mean that the same creatinine level can correspond to different eGFR values in different individuals
- Diet — high intake of cooked meat can transiently raise creatinine
Because of this variability, considering chronic kidney disease stages creatinine values without contextualising them through an eGFR calculation can be misleading. For urine-side context, see this urine creatinine ranges guide.
What Is the Creatinine Level for Stage 3 Kidney Disease?
This is one of the most commonly searched questions about CKD, and it deserves a direct and accurate answer.
There is no single creatinine level that defines CKD stage 3 for everyone.
CKD staging is based on eGFR — not creatinine in isolation. Because eGFR is calculated from creatinine alongside age, sex and other factors, two people with identical creatinine results can have meaningfully different eGFR values and therefore fall into different CKD categories.
For example, an older person with lower muscle mass may have a creatinine level that appears only mildly elevated, yet their eGFR may fall within the G3 range. A younger person with higher muscle mass might have a similar or even higher creatinine level, yet their eGFR could remain within the normal range.
Providing a universal creatinine cutoff for stage 3 kidney disease would therefore be medically inaccurate and potentially misleading. If you have received a creatinine result and wish to understand what it may indicate, that result should be interpreted alongside an eGFR calculation and discussed with an appropriate healthcare professional.
The Role of Urine Testing in Kidney Health Assessment
Blood tests provide important information about kidney function, but they offer only part of the picture. Urine testing can provide additional evidence relevant to kidney health assessment — and the relationship between kidney disease and urine findings is an important part of CKD evaluation.
One key urine marker is albumin — a protein that healthy kidneys normally prevent from passing into the urine in significant quantities. When albumin is detected in the urine (known as albuminuria), this can indicate that the kidney’s filtering units may be under stress or damaged. Urine albumin-to-creatinine ratio (uACR) is a commonly used measurement.
In CKD classification, urine findings complement eGFR. The KDIGO framework includes albuminuria categories (A1–A3) alongside the eGFR categories (G1–G5), meaning a complete CKD classification considers both dimensions.
A urine result alone does not diagnose CKD. Similarly, a normal urine result does not exclude all kidney concerns. Both blood and urine findings contribute to an overall picture, which is why this single-marker limits article can be useful.
Practical Insight: Kidney health assessment is most informative when it draws on multiple measurements over time — including both kidney-function blood markers and urine findings — rather than relying on any single test result.
CKD vs Kidney Failure: An Important Distinction
The terms CKD, kidney failure, and related abbreviations are sometimes used loosely in everyday language. Understanding the distinctions matters.
CKD covers a spectrum of kidney-function categories from G1 through to G5. The presence of CKD does not mean kidney failure. Many people with CKD — including those in G3 categories — are managed effectively and do not progress to kidney failure.
Kidney failure is generally associated with G5, where eGFR falls below 15 mL/min/1.73m². At this level, the kidneys may no longer be able to sustain adequate filtration, and kidney replacement therapy (such as dialysis or transplantation) may be required.
ESRD (end-stage renal disease) is a term used particularly in relation to kidney failure requiring replacement therapy. It is not synonymous with all stages of CKD.
Kidney renal failure stages and renal kidney disease stages are sometimes used in lay or older clinical contexts to describe the range of CKD severity, though modern frameworks prefer the G1–G5 eGFR categorisation.
The language around kidney disease can be alarming if misunderstood. CKD stage 3 is not kidney failure, and receiving a result that falls within a G3 range does not mean kidney failure is imminent or inevitable.
CRF, CKD and ESRD: Clarifying the Terminology
Medical abbreviations in kidney health can cause understandable confusion.
- CKD — Chronic Kidney Disease: the current internationally preferred term for persistent reduction in kidney function or evidence of kidney damage.
- CRF — Chronic Renal Failure: an older term that has largely been replaced by CKD in modern clinical practice, though it may still appear in some older documents or clinical records. CRF stages broadly correspond to the eGFR categories now used in CKD classification.
- ESRD — End-Stage Renal Disease: refers specifically to kidney failure requiring kidney replacement therapy (dialysis or transplantation). It corresponds broadly to CKD G5 with kidney failure.
These terms are not interchangeable, and understanding the difference helps when reading clinical letters, laboratory reports or health information.
When to Discuss Kidney-Function Results With a Healthcare Professional
If you have received kidney-function results — whether through NHS testing or as part of a private laboratory screen — and you have concerns about what they may indicate, it is appropriate to discuss those results with a healthcare professional.
Persistently reduced eGFR results, or those accompanied by abnormal urine findings, may warrant appropriate further assessment. A single abnormal result in the context of a temporary illness, dehydration or recent strenuous exercise may not reflect underlying kidney disease, but this judgement should be made by a qualified clinician with access to your full history.
Seek urgent medical care if you experience severe symptoms such as sudden, marked reduction in urine output, significant swelling, or any other acute symptom that concerns you.
Private health screening and laboratory testing can provide useful information about kidney-function biomarkers. Our structured screening packages may include kidney-function markers alongside other relevant health indicators. These tests provide laboratory data to support informed health conversations — they are not a substitute for clinical assessment by an appropriate healthcare professional.
Frequently Asked Questions
1. What does chronic kidney disease stage 3 mean?
Chronic kidney disease stage 3 — classified as G3 in the international CKD framework — refers to a moderate reduction in kidney function, with an eGFR between 30 and 59 mL/min/1.73m². It is divided into G3a (eGFR 45–59, mild to moderate reduction) and G3b (eGFR 30–44, moderate to severe reduction). These categories describe kidney function levels and do not constitute an individual diagnosis from a single result.
2. How many stages of chronic kidney disease are there?
There are five main CKD categories (G1–G5) based on eGFR, but because G3 is subdivided into G3a and G3b, the full classification system effectively comprises six eGFR categories. The stages range from G1 (eGFR ≥90, normal or high) through to G5 (eGFR <15, kidney failure). G1 and G2 require additional evidence of kidney damage to qualify as CKD.
3. What is the difference between G3a and G3b CKD?
G3a (eGFR 45–59) describes mild to moderately decreased kidney function, while G3b (eGFR 30–44) describes moderately to severely decreased kidney function. The distinction matters clinically because G3b may carry a greater risk of complications and more frequently warrants specialist renal review. Grouping both under a single "stage 3" label without this distinction could obscure important differences.
4. What is the creatinine level for stage 3 kidney disease?
There is no single creatinine level that defines CKD stage 3 for everyone. CKD staging is based on eGFR, not creatinine alone. Because eGFR is calculated using creatinine alongside age, sex and other factors, people with the same creatinine result can have different eGFR values. Creatinine is influenced by muscle mass, age, sex and diet, which is why eGFR is used for CKD classification rather than creatinine in isolation.
5. What eGFR is considered stage 3 kidney disease?
An eGFR of between 30 and 59 mL/min/1.73m² falls within the G3 (stage 3) range of the CKD classification framework. This is subdivided into G3a (eGFR 45–59) and G3b (eGFR 30–44). It is important to note that a single eGFR result in this range does not automatically establish CKD — persistence over at least three months, alongside relevant clinical context, is considered in classification.
6. Can one low eGFR result mean you have CKD?
Not necessarily. A single reduced eGFR can reflect temporary factors such as dehydration, acute illness or recent strenuous exercise rather than an underlying chronic condition. CKD classification generally requires persistent evidence of reduced kidney function or kidney damage over at least three months. Any abnormal result should be followed up with a healthcare professional, who can assess whether repeat testing and further evaluation are appropriate.
7. What is the difference between creatinine and eGFR?
Creatinine is a waste product filtered from the blood by the kidneys and measurable in a blood test. eGFR (estimated glomerular filtration rate) is a calculated figure that uses the creatinine result alongside age, sex and sometimes other factors to estimate how efficiently the kidneys are filtering blood. eGFR is more useful than creatinine alone for CKD classification because it accounts for individual differences that affect creatinine levels.
8. What does a CKD chart show?
A CKD chart — sometimes called a GFR stages chart or CKD table — maps eGFR values to recognised kidney-function categories (G1–G5, including G3a and G3b). It provides a reference framework for understanding where a particular eGFR result sits within the classification system. A complete CKD chart may also include albuminuria categories. The chart describes functional categories; it does not predict individual outcomes or indicate that progression between stages is inevitable.
9. Can urine tests provide information about kidney health?
Yes. Urine tests can provide information about kidney health that complements eGFR measurements. Detection of albumin (a protein) in the urine — measured as uACR (albumin-to-creatinine ratio) — can indicate potential kidney damage and is part of the full CKD classification framework. Neither a urine result nor a blood result alone is sufficient to establish or exclude CKD. Both contribute to the overall clinical picture when interpreted appropriately.
10. Is stage 3 kidney disease the same as kidney failure?
No. Stage 3 chronic kidney disease (G3a or G3b) describes a moderate reduction in kidney function. It is not the same as kidney failure. Kidney failure is associated with CKD G5, where eGFR falls below 15 mL/min/1.73m², and may require kidney replacement therapy such as dialysis or transplantation. Many people with CKD in the G3 range do not progress to kidney failure, particularly with appropriate monitoring and management of contributing conditions.
Understanding Your Kidney-Function Results
If you have received a kidney-function result — or are considering a health screen that includes kidney markers — taking time to understand what the numbers mean is a sensible step. You can book a kidney-focused screening to review relevant markers in one visit.
Kidney health does not exist in isolation. Risk factors for kidney disease often overlap with those for cardiovascular conditions, so interpreting results in a broader clinical context remains essential.
If your results indicate persistently reduced kidney function, or if you are concerned about any aspect of your health, discussing those findings with an appropriate healthcare professional is the most important next step.